Carepartners Hospice & Palliative Care Services Medicare Approved Location: 21 Belvedere Road, Asheville, North Carolina 28802 Phone: (828) 255-0231 |
News Archive
AVANIR Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a new patent for its lead drug candidate Zenvia™ (dextromethorphan/quinidine), extending the period of patent protection in the United States into late 2025. U.S. patent number 7,659,282 titled "Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders" was issued on February 9, 2010. The new patent will provide AVANIR with patent protection for low-dose quinidine formulations of Zenvia used to treat pseudobulbar affect (PBA).
Pregnancy and infancy are the periods of greatest vulnerability to the use of household insecticides. This is one of the findings of the first study of its kind to be carried out in Spain, which concludes that more than half of expectant mothers routinely use these chemical compounds.
Americans for Responsible Heath Care is launching an independent television advertisement campaign in the Boston media market to educate Americans about the dangerous health care proposal being debated in Congress.
Regardless of whether adults adopted in infancy consider their adoptions to play an important role in their lives or not, certain "trigger events" in adulthood may result in a greater emphasis being placed on their adoptive status, new research from the University of Melbourne has found.
Accuray Incorporated, a global leader in the field of radiosurgery, announced today that 20 percent of the company's U.S. installed base has signed on to utilize Accuray's Treatment Planning Service. This demonstrates a significant increase over the 10 percent of U.S. sites that had signed on as of February 2009.
› Verified 6 days ago